The ONE BioOS Platform
Cardiometabolic Monitoring
Cardiometabolic risk builds quietly for years before it shows up as a diagnosis. ONE BioOS continuously tracks the biomarkers and signals that reveal it early — glucose regulation, lipid transport, inflammation, and vascular stress.
Glucose & Insulin Regulation
Tracks blood sugar regulation and insulin sensitivity trends over time, flagging early signs of metabolic dysregulation long before a diagnosis.
Lipid Transport
Evaluates cholesterol particle behavior and lipid transport efficiency — a more complete picture than a standard cholesterol panel alone.
Inflammation
Monitors systemic inflammatory markers linked to cardiometabolic risk, catching low-grade inflammation that standard checkups often miss.
Vascular Stress
Tracks blood pressure and vascular load indicators to assess cardiovascular strain before it becomes symptomatic.
GLP-1 Sub-Module
Specialized monitoring for individuals using GLP-1 medications (Ozempic, Wegovy, etc.). Ensures fat loss doesn't compromise lean muscle or performance. Tracks protein intake, rate of loss, hormonal balance, and metabolic markers to keep you aligned with the OPL® framework.
Common questions
Cardiometabolic monitoring, explained
What is cardiometabolic health?
Cardiometabolic health covers how well your body regulates blood sugar, transports lipids, manages inflammation, and handles vascular load — the combined drivers of cardiovascular and metabolic disease risk.
How does ONE BioOS monitor cardiometabolic risk continuously?
The OPL® Engine correlates blood biomarkers with wearable and behavioral data, so glucose, lipid, inflammation, and vascular signals update continuously rather than only at your next lab draw.
Does it work for people on GLP-1 medications?
Yes — the GLP-1 sub-module specifically monitors protein intake, rate of weight loss, hormonal balance, and metabolic markers for people using medications like Ozempic or Wegovy, ensuring fat loss doesn't come at the cost of lean muscle or metabolic health.
See it in action
Catch cardiometabolic risk before it becomes a diagnosis
Deploy continuous cardiometabolic monitoring as a workforce wellness benefit — with individual guidance and HR-level dashboards.